ALLURION TECHNOLOGIES INC (ALUR) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:ALUR - US02008G2012 - Common Stock
ALUR Key Statistics, Chart & Performance
The current stock price of ALUR is 1.38 USD. In the past month the price increased by 22.12%. In the past year, price decreased by -87.3%.
ALUR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SCI | SERVICE CORP INTERNATIONAL | 20.78 | 10.98B | ||
| ADT | ADT INC | 9.26 | 6.61B | ||
| HRB | H&R BLOCK INC | 9.17 | 5.47B | ||
| FTDR | FRONTDOOR INC | 14.07 | 4.18B | ||
| DRVN | DRIVEN BRANDS HOLDINGS INC | 11.75 | 2.45B | ||
| MCW | MISTER CAR WASH INC | 13.64 | 1.88B | ||
| MATW | MATTHEWS INTL CORP-CLASS A | 20.6 | 799.26M | ||
| CSV | CARRIAGE SERVICES INC | 13.84 | 669.38M | ||
| WW | WW INTERNATIONAL INC-NEW | 37.01 | 303.20M | ||
| EWCZ | EUROPEAN WAX CENTER INC-A | 3.98 | 196.78M | ||
| BODI | BEACHBODY CO INC/THE | N/A | 76.00M | ||
| RGS | REGIS CORP | 0.81 | 70.63M |
Related stock screener links
About ALUR
Company Profile
Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 134 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Company Info
ALLURION TECHNOLOGIES INC
11 Huron Dr Ste 200
Natick MASSACHUSETTS US
Employees: 136
Phone: 15086474000
ALLURION TECHNOLOGIES INC / ALUR FAQ
What does ALUR do?
Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 134 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
What is the current price of ALUR stock?
The current stock price of ALUR is 1.38 USD. The price decreased by -1.43% in the last trading session.
Does ALUR stock pay dividends?
ALUR does not pay a dividend.
What is the ChartMill technical and fundamental rating of ALUR stock?
ALUR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of ALUR stock?
ALLURION TECHNOLOGIES INC (ALUR) operates in the Consumer Discretionary sector and the Diversified Consumer Services industry.
Is ALLURION TECHNOLOGIES INC (ALUR) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALUR.
ALUR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ALUR. When comparing the yearly performance of all stocks, ALUR is a bad performer in the overall market: 96.6% of all stocks are doing better.
ALUR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALUR. ALUR may be in some trouble as it scores bad on both profitability and health.
ALUR Financial Highlights
Over the last trailing twelve months ALUR reported a non-GAAP Earnings per Share(EPS) of -7.17. The EPS decreased by -172.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -80.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALUR Forecast & Estimates
9 analysts have analysed ALUR and the average price target is 5.61 USD. This implies a price increase of 306.52% is expected in the next year compared to the current price of 1.38.
For the next year, analysts expect an EPS growth of 65.28% and a revenue growth -54.99% for ALUR